These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 19084156)

  • 1. Effect of antibacterials on biofilms.
    Aslam S
    Am J Infect Control; 2008 Dec; 36(10):S175.e9-11. PubMed ID: 19084156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
    Raad II; Fang X; Keutgen XM; Jiang Y; Sherertz R; Hachem R
    Curr Opin Infect Dis; 2008 Aug; 21(4):385-92. PubMed ID: 18594291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters.
    Aslam S; Trautner BW; Ramanathan V; Darouiche RO
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1556-8. PubMed ID: 17220399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.
    Cafiso V; Bertuccio T; Spina D; Purrello S; Stefani S
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):466-9. PubMed ID: 20528931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilms on medical devices.
    Talsma SS
    Home Healthc Nurse; 2007 Oct; 25(9):589-94. PubMed ID: 18049256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model.
    Murga R; Miller JM; Donlan RM
    J Clin Microbiol; 2001 Jun; 39(6):2294-7. PubMed ID: 11376074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilms on central venous catheters: is eradication possible?
    Donlan RM
    Curr Top Microbiol Immunol; 2008; 322():133-61. PubMed ID: 18453275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS; Abbanat D
    Expert Opin Ther Pat; 2010 Oct; 20(10):1373-87. PubMed ID: 20636186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biofilm, foreign bodies and chronic infections].
    Høiby N; Espersen F; Fomsgaard A; Giwercman B; Jensen ET; Johansen HK; Koch C; Kronborg G; Pedersen SS; Pressler T
    Ugeskr Laeger; 1994 Oct; 156(41):5998-6005. PubMed ID: 7992437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm formation: a clinically relevant microbiological process.
    Donlan RM
    Clin Infect Dis; 2001 Oct; 33(8):1387-92. PubMed ID: 11565080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.
    Donlan RM
    Clin Infect Dis; 2011 Apr; 52(8):1038-45. PubMed ID: 21460321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies for central venous catheter infections.
    Sabatier C; Ferrer R; Vallés J
    Expert Opin Pharmacother; 2009 Oct; 10(14):2231-43. PubMed ID: 19751104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections.
    Passerini de Rossi B; Calenda M; Vay C; Franco M
    Rev Argent Microbiol; 2007; 39(4):204-12. PubMed ID: 18390153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.